News
Humana's stock has shown resilience, boosted by a 5% increase in Medicare Advantage payments. Read my analysis of HUM stock.
Guggenheim analyst Jason Cassorla initiated coverage of Humana (HUM) with a Buy rating and $326 price target The firm launched coverage on 11 ...
11d
Zacks Investment Research on MSNUnitedHealth vs. Humana: Which Healthcare Stock Should You Buy Now?UnitedHealth Group Incorporated UNH and Humana Inc. HUM are two of the most prominent players in the U.S. health insurance ...
The CMS announced a 5.06% expected average change in revenue for 2026 Medicare ... of pressure on many insurance stocks last year. But Humana Inc.'s stock (HUM) rose more than 11% in Monday's ...
Hosted on MSN19d
Humana Inc (NYSE:HUM): A Bullish Investment PerspectiveWe came across a long thesis on Humana Inc (NYSE:HUM ... from seniors returning to healthcare post-COVID, as well as changes to risk coding intensity (V28), which represents a short-term ...
Humana Inc. lost an administrative appeal in its ongoing battle to reverse changes to Medicare quality ratings that threaten ...
In a report released today, Andrew Mok CFA from Barclays maintained a Hold rating on Humana (HUM – Research Report), with a price target of ...
Harbour Investments Inc.’s holdings in Humana were worth $80,000 as of its most recent SEC filing. A number of other hedge funds also recently bought and sold shares of HUM.
LOUISVILLE, Ky., April 09, 2025--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, today released its 2024 Impact Report, showcasing the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results